Humana Inc. earnings overview

HUM FY2026 Q1 · Calendar Q2 2026

Humana Inc.

Humana's first quarter reinforced the trajectory management laid out last quarter: membership is still growing, the Max Health acquisition is expanding CenterWell's primary-care footprint, and operational efficiencies are beginning to flow through. The company reaffirmed 2026 guidance and remains on track for its 2028 sustainable margin goal of at least 3%. The stock reacted strongly, with an abnormal move of nearly 6% on the report and a subsequent drift of roughly 27%, suggesting the market is gaining confidence in the margin recovery story. The key tension is between that forward narrative and near-term pressures: a 35% sequential jump in IBNR reserves, a persistent funding gap between medical cost trends and CMS rates, and potential $1 to $1.5 billion in cash outflows from Welsh Carson put/call options in 2027 to 2028.